Mike Buckingham is currently the B2B Director for the Cardiometabolic Health team at Eli Lilly, overseeing the UK Private Ecosystem since 2026. Prior to this role, Mike served in various capacities within Eli Lilly, including Regional Business Manager and Healthcare Development and Access Manager. They hold a Diploma of Education in Health Outcome Research and Health Economy from the Vienna School of Clinical Research & Public Health, as well as multiple degrees in exercise science and health from Cardiff Metropolitan University and the University of Wales Trinity Saint David. Mike is dedicated to building authentic, high-impact relationships in the healthcare sector.
This person is not in the org chart
This person is not in any teams
This person is not in any offices